![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
外围T细胞淋巴瘤的进展:病原体,遗传景观和新兴的治疗点
Alexander S Pichler1, Catalina Amador2, Ayumi Fujimoto3
1Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Histopathology
|December 16, 2024
概括
周围T细胞淋巴瘤 (PTCL) 是一种攻击性癌症. 尽管取得了进展,但诊断和治疗仍然具有挑战性,需要基于详细的生物分析的新型个性化治疗策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 周围T细胞淋巴瘤 (PTCLs) 是一种多样化和侵略性的非霍奇金淋巴瘤类别.
- PTCL源于成熟的T细胞,经常表现出复杂的临床和形态特征.
研究的目的:
- 审查与PTCLs相关的诊断和分类挑战.
- 探索常见节点PTCL实体的复杂生物学.
- 讨论分子诊断对了解PTCL的影响以及改善治疗策略的需要.
主要方法:
- 审查关于PTCL诊断,分类和分子分析的当前文献.
- 分析分子诊断方面的进展,包括突变和基因表达分析.
- 检查PTCL稀有性和形态变异性所带来的挑战.
主要成果:
- 分子诊断提高了对PTCL生物学的理解.
- 目前的诊断分类仍然很复杂,尚未导致改善临床结果.
- 标准疗法往往是无效的,导致大多数患者的预后不佳.
结论:
- 精确描述PTCL对于完善分类和开发向治疗至关重要.
- 基于生物学的风险分层正在成为个性化治疗选择的关键方法.
- 未来的战略重点是利用遗传,表观遗传和功能特征来改善患者的治疗结果.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
639
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475